Results 71 to 80 of about 13,547 (178)

Computer-Aided Approaches for Targeting HIVgp41

open access: yesBiology, 2012
Virus-cell fusion is the primary means by which the human immunodeficiency virus-1 (HIV) delivers its genetic material into the human T-cell host. Fusion is mediated in large part by the viral glycoprotein 41 (gp41) which advances through four distinct ...
William J. Allen, Robert C. Rizzo
doaj   +1 more source

HIV-1 Induced Bystander Apoptosis

open access: yesViruses, 2012
Apoptosis of uninfected bystander cells is a key element of HIV pathogenesis and believed to be the driving force behind the selective depletion of CD4+ T cells leading to immunodeficiency.
Anjali Joshi   +2 more
doaj   +1 more source

Use of silver nanoparticles increased inhibition of cell-associated HIV-1 infection by neutralizing antibodies developed against HIV-1 envelope proteins

open access: yesJournal of Nanobiotechnology, 2011
Background HIV/AIDS pandemic is a worldwide public health issue. There is a need for new approaches to develop new antiviral compounds or other therapeutic strategies to limit viral transmission.
Garza Treviño Elsa N   +3 more
doaj   +1 more source

HIV-1 gp41-targeting fusion inhibitory peptides enhance the gp120-targeting protein-mediated inactivation of HIV-1 virions

open access: yesEmerging Microbes and Infections, 2017
Protein- or peptide-based viral inactivators are being developed as novel antiviral drugs with improved efficacy, pharmacokinetics and toxicity profiles because they actively inactivate cell-free human immunodeficiency virus type 1 (HIV-1) virions before
Qianqian Qi   +6 more
doaj   +1 more source

HIV gp41 [PDF]

open access: yesScience-Business eXchange, 2008
openaire   +1 more source

ADS-J21 is a novel HIV-1 entry inhibitor targeting gp41

open access: yesCurrent Research in Microbial Sciences
HIV-1 envelope glycoprotein gp41 mediates fusion between HIV-1 and host cell membranes, making inhibitors of gp41 attractive anti-HIV drugs. We previously reported an efficient HIV-1 fusion inhibitor, ADS-J1, with a Y-shaped structure.
Ruiying Liang   +12 more
doaj   +1 more source

Home - About - Disclaimer - Privacy